The Next Steps for Amyloid Light Chain Amyloidosis Treatment

Conference|ASH Annual Meeting and Exposition - American Society of Hematology Annual Meeting and Exposition

Pharmacy Times interviewed Jason Valent, MD, of the Cleveland Clinic the next steps for his CAEL-101 findings, a treatment for patients living with amyloid light chain amyloidosis.

Pharmacy Times^® interviewed Jason Valent, MD, of the Cleveland Clinic the next steps for his CAEL-101 findings, a treatment for patients living with amyloid light chain amyloidosis. His research surrounding the therapy was presented at the 62^nd American Society of Hematology Annual Meeting & Exposition.

The full conversation can be found in the video above.